We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2016 09:22 | If I could I would but already top heavy in OPTI. Been buying in small batches for some time. | rafboy | |
06/12/2016 09:13 | can you buy some more and round it up to 100,000, tia | neftanikoff | |
06/12/2016 08:41 | Just bought 3819 shares at 64.18p!! | rafboy | |
05/12/2016 20:28 | I think most of us agree Skinbiotix will be a significant kickers for the recovery of the share price, but it will not be the only kicker. SOH has said there is lot to come and he is confidents about the deals. The sugar tax argument is not going away, the government has confirmed its commitment higher tax on high sugar content fizzy drinks, which clearly offers huge scope for our novel sugar IP and strains. No amount of educating people high sugar content and the damage it does will have a positive impact on them if they don't have the willpower. Some will argue it is their choice, so with OPTI novel sugar, they they have the choice with no obesity related issues. IMHO a key area for 2017. | elrico | |
05/12/2016 17:05 | Elrico, you are right we've made our cases. To the relief of most here, I don't have anything else to add for the foreseeable other than I believe the best opportunity for share price turnaround next year will be the skin division. | mazzstar | |
05/12/2016 17:00 | Mazz - Do me a favour stick to facts, please. I have not accused you of anything, I just think we have a different opinion. You state you can read between the lines, great, but like me or anyone, it's guess work open to opinions. So, please stop changing the syntax of my comments, it does you no favours. You have made your case, I have made mine, so let's see how it plays out. No matter whom is right or wrong, it don't need to be turned into a personal attack...I'm sure we have both been wrong before - we survived against all the odds. | elrico | |
05/12/2016 16:38 | A deramping squib? | owenmo | |
05/12/2016 15:53 | squib not squid | mazzstar | |
05/12/2016 15:51 | A deramping squid | owenmo | |
05/12/2016 15:38 | Mazzstar you talk absolute rubbish. Do us all a favour and join the mouse with your ridiculous comments. Saying that the cholesterol product will be damp squid, you are a fool. Do not trust this de-ramper. | primal123 | |
05/12/2016 15:24 | RNS update on 26/10 was a big hint to investors that there would be no deals by the end of November. It is my opinion RNS update on 29/11 was another big hint that there would be no forthcoming deals this month and who knows how long. Elrico and Co can accus me all sorts of things but I can read between the lines of the recent RNS's and in my opinion, cholesterol product will be another damp squib. I remain invested solely for skin division. | mazzstar | |
05/12/2016 15:23 | Oh I'm saying yes, as I think SOH would like to go into 2017 on a strong growth note, given that 2016 has been more consolidation and negotiation. | 1bokke | |
05/12/2016 15:07 | All this waiting is driving me to mince pies!! Anyone want to guess on the first deal being announced before Xmas? | 1bokke | |
05/12/2016 10:55 | Mazz - do us all a favour, please. Pop over to the michaelmouse thread, there's a good chap. | elrico | |
05/12/2016 08:42 | JH, all jam deals until confirmed. And even with a partner on board, if it's an unknown like 'healthy weight loss' rather than MN then short to medium term the share price will slide given the SOH hype of waiting for the right deal for over a year or that is what he's lead investors to believe. | mazzstar | |
05/12/2016 07:57 | Mazzstar you haven't really understood the recent updates have you. There will be multiple deals with different partners involving a range of cholesterol products. | john henry | |
05/12/2016 00:49 | Oh please, stop ramping the rubbish. Soon there will be a push to put this pos on a toast instead of marmite or butter. | rwauu | |
05/12/2016 00:45 | Rubbish. What do they actually make? Splenda???? Must be on the top of a world! | rwauu | |
05/12/2016 00:34 | Monkey, more like 40p in 4 months if cholesterol product is another Go Figure. Neftan, ignoring me will not change this fact. | mazzstar | |
04/12/2016 23:55 | I am new to investing and asked questions. I am not trying to rob you. Did you ever ask questions? My auntie passed recently and left me with shares. I knew she used this site and it came up in google so i joined hoping i could learn something. Why are some of you so suspicious? I am not trying to scam you. | pglancy | |
04/12/2016 23:27 | I can't see why some people even bother, just so it is clear , pglancy is a member since 1/12/16 and is most likely either a mouse, monkey, mazz or some other creature who is best ignored. Advfn is full of snakes, that's how it is, i don't know what they hope to achieve with their nonsense. ps, coming on here under some ludicrous story and as such must think everyone on these boards is of very low intelligence to be taken in, maybe some are. | neftanikoff | |
04/12/2016 22:53 | Still approx 4 months from 100p. | monkeywench1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions